Skip to main content
Log in

76/w mit subakuter Gangstörung und gelblicher Blässe

Vorbereitung auf die Facharztprüfung: Fall 3

76/f—Subacute gait disturbance and yellowish pallor

Preparation for the medical specialist examination: part 3

  • Facharzt-Training
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Carmel R (2008) How I treat cobalamin (vitamin B12) deficiency. Blood 112(6):2214–2221. https://doi.org/10.1182/blood-2008-03-040253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Langan RC, Goodbred AJ (2017) Vitamin B12 deficiency: recognition and management. Am Fam Physician 96(6):384–389

    PubMed  Google Scholar 

  3. Jarquin Campos A, Risch L, Nydegger U, Wiesner J, Vazquez Van Dyck M, Renz H et al (2020) Diagnostic accuracy of holotranscobalamin, vitamin B12, Methylmalonic acid, and homocysteine in detecting B12 deficiency in a large, mixed patient population. Dis Markers. https://doi.org/10.1155/2020/7468506

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bjørke Monsen AL, Ueland PM (2003) Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr 78(1):7–21. https://doi.org/10.1093/ajcn/78.1.7

    Article  PubMed  Google Scholar 

  5. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (2018) Harrison’s Principles of Internal Medicine, 20. Aufl. Bd. 1, 2. McGraw-Hill,

    Google Scholar 

  6. Bensky MJ, Ayalon-Dangur I, Ayalon-Dangur R, Naamany E, Gafter-Gvili A, Koren G et al (2019) Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency. Drug Deliv Transl Res 9(3):625–630. https://doi.org/10.1007/s13346-018-00613-y

    Article  CAS  PubMed  Google Scholar 

  7. Chaudhuri BP, Ceyssens F, Celen S, Bormans G, Kraft M, Puers R (2019) In-vivo intradermal delivery of co-57 labeled vitamin B‑12, and subsequent comparison with standard subcutaneous administration(). Annu Int Conf IEEE Eng Med Biol Soc, S 1670–1673 https://doi.org/10.1109/embc.2019.8857543

    Book  Google Scholar 

  8. Masucci L, Goeree R (2013) Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis. Ont Health Technol Assess Ser 13(24):1–24

    PubMed  PubMed Central  Google Scholar 

  9. Sezer RG, Akoğlu HA, Bozaykut A, Özdemir GN (2018) Comparison of the efficacy of parenteral and oral treatment for nutritional vitamin B12 deficiency in children. Hematology 23(9):653–657. https://doi.org/10.1080/10245332.2018.1456023

    Article  CAS  PubMed  Google Scholar 

  10. Tillemans MPH, Donders EMVJ, Verweij SL, Van der Hoeven RTM, Kalisvaart KJ (2014) Effect of administration route on the pharmacokinetics of cobalamin in elderly patients: a randomized controlled trial. Curr Ther Res Clin Exp 76:21–25. https://doi.org/10.1016/j.curtheres.2014.01.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A et al (2005) Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004655.pub2

    Article  PubMed  Google Scholar 

  12. Tefferi A, Pruthi RK (1994) The biochemical basis of cobalamin deficiency. Mayo Clin Proc 69(2):181–186. https://doi.org/10.1016/s0025-6196(12)61046-5

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang Bethge MD.

Ethics declarations

Interessenkonflikt

J. Weller und W. Bethge geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Der Verlauf der Kasuistik und die Laborparameter sind bewusst leicht abgeändert worden, sodass eine Identifikation der/des betroffenen Patient*in nicht möglich ist.

The supplement containing this article is not sponsored by industry.

Additional information

Redaktion

M. Christopeit, Tübingen

Ch. Oing, Hamburg

K. Hoeffken, Jena

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weller, J.F., Bethge, W. 76/w mit subakuter Gangstörung und gelblicher Blässe. Onkologe 27 (Suppl 1), 18–26 (2021). https://doi.org/10.1007/s00761-021-00922-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-021-00922-x

Schlüsselwörter

Navigation